SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-027388
Filing Date
2018-11-06
Accepted
2018-11-06 16:02:36
Documents
56
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cbay-10q_20180930.htm 10-Q 1781977
2 EX-10.1 cbay-ex101_250.htm EX-10.1 75426
3 EX-31.1 cbay-ex311_8.htm EX-31.1 15440
4 EX-31.2 cbay-ex312_6.htm EX-31.2 15343
5 EX-32.1 cbay-ex321_7.htm EX-32.1 8019
6 GRAPHIC gm1vhleorqqq000001.jpg GRAPHIC 3633
  Complete submission text file 0001564590-18-027388.txt   7230346

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cbay-20180930.xml EX-101.INS 1944546
8 XBRL TAXONOMY EXTENSION SCHEMA cbay-20180930.xsd EX-101.SCH 38698
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbay-20180930_cal.xml EX-101.CAL 44398
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbay-20180930_def.xml EX-101.DEF 104332
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbay-20180930_lab.xml EX-101.LAB 289944
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbay-20180930_pre.xml EX-101.PRE 218635
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36500 | Film No.: 181162932
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1